Recurrent drug shortages signal onerous outlook for cardiovascular care
Pharmaceutical Technology
NOVEMBER 3, 2022
According to the agency, shortages of both drugs are expected to last until 2024, as a result of growing demand. This is due to aging populations around the world, which leads to an increased risk of such conditions, explains Craig Beavers, PhD, assistant professor at the University of Kentucky’s College of Pharmacy in Lexington.
111 
Let's personalize your content